Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 747 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Motility Disorders Clear all

Conditions: GERD, Gastroesophageal Reflux, Gastroparesis
Interventions: Domperidone; Drug
Lead sponsor: Jose Cocjin; Other
Eligibility: 12 Years to 21 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2035
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Postoperative Ileus, Postoperative Nausea, Postoperative Complications, Postoperative Nausea and Vomiting, Postoperative Vomiting, Aspiration Vomitus
Interventions: Bedside gastric ultrasound; Diagnostic Test
Lead sponsor: Eric Schwenk; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gastroesophageal Reflux
Interventions: maltosyl-isomalto-oligosaccharides (MIMO); Dietary Supplement
Lead sponsor: ISOThrive Inc.; Industry
Eligibility: 25 Years to 75 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Manassas, Virginia

Conditions: Binocular Vision Disorder, Convergence Insufficiency, Computer Vision Syndrome
Interventions: Neurolens spectacle lens, Placebo spectacle lens; Device
Lead sponsor: Neurolens Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 9
States / cities: Brea, California • Fort Collins, Colorado • Manchester, Connecticut + 6 more

Conditions: Barrett's Esophagus, Gastroesophageal Reflux Disease
Interventions: Cessation of Acid Suppressing Medications; Other
Lead sponsor: Dallas VA Medical Center; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Progressive Supranuclear Palsy
Interventions: Single dose C2N-8E12, Single dose placebo; Drug
Lead sponsor: C2N Diagnostics; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 12
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 9 more

Conditions: Gastroesophageal Reflux Disease, Hiatal Hernia
Interventions: Lap. Fundo. with Mobilization of the Esophageal Junction, Lap. Fundo. without Mobilization of the Esophageal Junction; Procedure
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Up to 18 Years
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Birmingham, Alabama • Kansas City, Missouri

Conditions: Exotropia
Interventions: Bilateral lateral rectus recession (BLRc), Unilateral lateral rectus recession with medial rectus resection (R&R); Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 10 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Achalasia
Interventions: ValACYclovir 1000 MG, Shingrix; Drug · Biological
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cataract, Ophthalmoplegia, Ophthalmologic Complication
Interventions: MORCHER® EYEJET® CTR Types 14, 14A, and 14C, Toric IOL Only; Device
Lead sponsor: Rachel Lieberman; Federal
Eligibility: 30 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Conditions: Systemic Sclerosis, Constipation, Gastrointestinal Motility Disorder, Autonomic Dysfunction
Interventions: Transcutaneous Electrical Acustimulation (TEA), Sham-TEA; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gastroesophageal Reflux Disease
Interventions: Acupuncture, Sham Acupuncture, Yoga; Procedure · Other
Lead sponsor: Midwest Biomedical Research; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus, Ataxia
Interventions: rituximab; Drug
Lead sponsor: National Pediatric Neuroinflammation Organization, Inc.; Other
Eligibility: 6 Months to 19 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Gastroesophageal Reflux
Interventions: Lifestyle Modifications; Behavioral
Lead sponsor: Mount Carmel Health System; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Westerville, Ohio

Conditions: Esophageal Achalasia, Achalasia, Achalasia, Esophageal
Interventions: Questionnaires; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 19 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: Esomeprazole (Nexium); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 28
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Wilmington, Delaware + 25 more

Conditions: Dysphagia, GERD, Abdominal Pain
Interventions: Lidocaine, Placebo; Drug
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Achalasia
Interventions: POEM Procedure; Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Secondary Hypogonadism
Interventions: 25 mg Androxal, Testim 1%; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 21 Years to 60 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: New York, New York • Purchase, New York

Conditions: Emergence Delirium, Strabismus
Interventions: Methadone; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 0 Years to 18 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Jefferson, Louisiana

Conditions: Progressive Supranuclear Palsy (PSP)
Interventions: ABBV-8E12; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: La Jolla, California • Dallas, Texas

Conditions: Laryngopharyngeal Reflux, Zenker's Diverticulum
Interventions: Cricopharyngeal myotomy, PH probe Testing; Procedure · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Barrett's Esophagus, Erosive Esophagitis, Gastroesophageal Reflux Disease(GERD)
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 75 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Laryngopharyngeal Reflux
Interventions: Prevacid; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Sacramento, California

Search by objective public record fields.

Compassionate Use of Domperidone for Refractory Gastroparesis

Assessing Gastric Motility and Distention in Postoperative Gastrointestinal Surgery Using Bedside Gastric Ultrasound: Predicting Risk of Aspiration Pneumonia, Ileus, Return of Bowel Function

Tolerability Study of a Novel Microbiome Therapeutic in Subjects With Gastroesophageal Reflux Disease

Neurolens Convergence Insufficiency Study

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Necessity of Esophageal Dissection During Laparoscopic Fundoplication

Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia

VZV in the Enteric Nervous System: Pathogenesis and Consequences

Capsular Tension Rings in Intraocular Lens Rotation

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients

Effectiveness of Rituximab in Pediatric OMS Patients.

Determining Risk Factors for Successful PPI Weaning

Achalasia Patient Reported Outcomes

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time

Peroral Endoscopic Myotomy (POEM) for Esophageal Motility

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy

To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux